FDA Adverse Event Injury Summary report: N

RX HERCULINK 14 STENT SYSTEM

MDR report key: 2080859 · Received May 6, 2011

Report

Report Number
2024168-2011-03275
Event Type
Injury
Date Received
May 6, 2011
Date of Event
February 13, 2011
Report Date
April 13, 2011
Manufacturer
AV-TEMECULA-CT
Product Code
FGE
PMA / PMN Number
K063481
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
MI, US
Reporter Occupation
HEALTH PROFESSIONAL

Narratives

Additional Manufacturer Narrative · 1

(B)(4). DURING PROCESSING OF THIS COMPLAINT, ATTEMPTS WERE MADE TO OBTAIN COMPLETE EVENT, PATIENT AND DEVICE INFORMATION. BILIARY STENT USED OUTSIDE OF THE BILIARY TREE. DATE OF OCCURRENCE ESTIMATED AS (B)(6) 2011. THERE WAS NO REPORTED PRODUCT DEFICIENCY. ALTHOUGH A CONCLUSIVE CAUSE FOR THE REPORTED PATIENT EFFECTS AND THE RELATIONSHIP TO THE DEVICE, IF ANY, CANNOT BE DETERMINED, THERE IS NO INDICATION OF A PRODUCT QUALITY DEFICIENCY WITH RESPECT TO MANUFACTURE, DESIGN, OR LABELING. PER THE HERCULINK INSTRUCTIONS FOR USE (IFU), THE HERCULINK STENT SYSTEM IS INTENDED TO TREAT MALIGNANT STRICTURES IN THE BILIARY TREE. TWO UNKNOWN HERCULINK STENT SYSTEMS WERE USED OUTSIDE OF THE BILIARY TREE, WHICH ARE NOT INDICATED SITES FOR THIS DEVICE. THERE IS NO INDICATION THAT THIS USE LED TO THE REPORTED PATIENT EFFECTS OF NAUSEA AND HYPERSENSITIVITY. THE PROMUS STENT IS BEING REPORTED UNDER A SEPARATE MEDWATCH REPORT NUMBER.

Description of Event or Problem · 1

IT WAS REPORTED THAT APPROXIMATELY 2 WEEKS POST IMPLANTATION OF 2 HERCULINK STENTS AND 1 PROMUS STENT IN THE SUPERIOR MESENTERIC, CELIAC AND INFERIOR MESENTERIC ARTERIES, THE PATIENT EXPERIENCED NAUSEA AND A RASH. ON (B)(6) 2011, THE PATIENT WAS SEEN BY THEIR PHYSICIAN. PLAVIX WAS DISCONTINUED. THE PATIENT WILL BE TESTED FOR ALLERGIES TO BOTH STENTS. ALTHOUGH REQUESTED, THERE WAS NO ADDITIONAL INFORMATION PROVIDED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 RX HERCULINK 14 STENT SYSTEM BILIARY STENT SYSTEM FGE AV-TEMECULA-CT

Patients

Seq Age Sex Outcome Treatment
1 60 YR Other STENTS: PROMUS, HERCULINKPLAVIX, ASPIRIN